Advertisement

S-Adenosyl-L-Methionine (SAMe) and Biogenic Amine Methylation Processes

  • G. Stramentinoli
  • F. Maffei
Part of the Monographien aus dem Gesamtgebiete der Psychiatrie book series (PSYCHIATRIE, volume 18)

Abstract

Among catecholamines, norepinephrine (NE) and dopamine (DA) serve as synaptic mediators in the central nervous system (CNS). The dopaminergic pathways constitute the ascending nigrostriatal system and connect the dorsal neurons of the interpeduncular nucleus with the accumbens nucleus and the olfactory tubercle (20). The noradrenergic pathways, all of them ascending, originate from neurons in the pons and medulla oblongata and spread partly to the hypothalamus, preoptic area, septum, amygdala, hippocampus, and cingulate gyrus, and partly to the neocortex.

Keywords

Vanillic Acid Preoptic Area Methyl Donor Methylation Process Dihydroxybenzoic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andreoli, V.: Anfetamine, loro derivati e comportamento. In: Quaderni di Neuro-psicofarmacologia. Andreoli, V., Del Mastro, S., (eds.), Milano: 1971Google Scholar
  2. 2.
    Andreoli, V., Maffei, F., Tonon, G.C.: The subcellular distribution of S-adenosyl-L-methionine (SAMe) in the rat brain. This volume, p. 178Google Scholar
  3. 3.
    Antun, F.T., Burnett, G.B., Cooper, A.J., Daly, R., Smythies, J.R., Zealley, A.K.: The effects of L-methionine (without MAOI) in schizophrenics. J. psychiat. Res. 8, 63 (1971)PubMedCrossRefGoogle Scholar
  4. 4.
    Antun, F., Eccleston, D., Smythies, J.R.: Transmethylation processes in schizophrenia. In: Brain Chemistry and Mental Disease. Ho, B.T., Mclsaac, W.M. (eds.) New York: Plenum 1971, pp. 61–71CrossRefGoogle Scholar
  5. 5.
    Axelrod, J.: Methyltransferase enzyme in the metabolism of physiologically active compounds and drugs. In: Handbook of Experimental Pharmacology. Eichler, O., Farah, H., Herken, H., Welch, A.D. (eds.) New York: 1971, Vol. XXVIII/2, p. 610Google Scholar
  6. 6.
    Axelrod, J., Tomchick, R.J.: Enzymatic O-methylation of epinephrine and other catechols. J. biol. Chem. 233, 702 (1958)PubMedGoogle Scholar
  7. 7.
    Baldessarini, R.J., Kopin, I.J.: S-adenosylmethionine in brain and other tissues. J. Neurochem. 13, 769 (1966)PubMedCrossRefGoogle Scholar
  8. 8.
    Blaschko, H.: Formation of catechol amines in the animal body. Brit. med. Bull. 13, 162 (1957)PubMedGoogle Scholar
  9. 9.
    Blaschko, H.: Catecholamine biosynthesis. Brit. med. Bull. 29, 105 (1973)Google Scholar
  10. 10.
    Fazio, C, Andreoli, V., Agnoli, A., Casacchia, M., Cerbo, R., Pinzello, A.: Therapy of schizophrenia and depressive disorders with S-adenosyl-L-methionine. Intern. Res. Comm. System (IRCS), Clin. Pharmacol. Ther. 2, 1015 (1974)Google Scholar
  11. 11.
    Friedhoff, A.J.: Biogenic amines and schizophrenia. In: Biological Psychiatry. Mendels, J. (ed.) New York: Wiley, 1973, pp. 113–129Google Scholar
  12. 12.
    Friedhoff, A.J., Schweitzer, J.W., Miller, J.: The enzymatic formation of 3,4-di-O-methylated dopamine metabolites by mammalian tissues. Res. Commun. Path. Pharmacol. 3, 293 (1972)Google Scholar
  13. 13.
    Kakimoto Y., Sano, I., Kanazawa, A., Tsujio, T., Kaneko, Z.: Metabolic effects of methionine in schizophrenic patients pretreated with a monoamine oxidase inhibitor. Nature (Lond.) 216, 1110 (1967)CrossRefGoogle Scholar
  14. 14.
    Kirshner, N., McGoodall, C: The formation of adrenaline from noradrenaline. Biochim. biophys. Acta 24, 658 (1957)PubMedCrossRefGoogle Scholar
  15. 15.
    Kitabchi, A.E., Williams, R.H.: Phenylethanolamine-N-methyltransferase in human adrenal gland. Biochim. Biophys. Acta 178, 181 (1969)PubMedCrossRefGoogle Scholar
  16. 16.
    Mandell, A.J., Segal, D.S.: The psychobiology of dopamine and the methylated in-doleamines with particular reference to psychiatry. In: Biological Psychiatry. Mendels, J. (ed.) New York: Wiley, 1973, p. 89Google Scholar
  17. 17.
    McGeer, P.L., McGeer, E.G.: Formation of adrenaline by brain tissue. Biochem. biophys. Res. Commun. 17, 502 (1964)CrossRefGoogle Scholar
  18. 18.
    Mendels, J., Stinnett, J.L.: Biogenic amine metabolism. Depression and mania. In: Biological Psychiatry. Mendels, J. (ed.) New York: Wiley, 1973, pp. 35–64Google Scholar
  19. 19.
    Saavedra, J.M., Axelrod, J.: Psychotomimetic N-methylated tryptamine formation in brain in vivo and in vitro. Science 175, 1365 (1972)PubMedCrossRefGoogle Scholar
  20. 20.
    Snyder, S.H., Banerjee, S.P., Yamamura, H.I., Greenberg, D.: Drugs, neurotransmitters, and schizophrenia. Science 184, 1243 (1974)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1978

Authors and Affiliations

  • G. Stramentinoli
    • 1
  • F. Maffei
    • 2
  1. 1.Department of BiochemistryBioResearch CompanyLiscate (Milan)Italy
  2. 2.Neuropsychiatric HospitalsVeronaItaly

Personalised recommendations